Tag Archives: Progressive Multifocal Leukoencephalopathy

Tysabri (natalizumab) Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Tysabri (natalizumab): Drug Safety Communication – New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML) AUDIENCE: Neurology, Gastroenterology ISSUE: FDA notified healthcare profesisonals that testing positive for anti-JC virus (JCV) … Continue reading

Share
Posted in FDA 2012, FDA Notice, Gastroenterology, Neurology | Tagged , , , , , , , , | Comments Off

Adcetris (brentuximab vedotin) Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseAdcetris (brentuximab vedotin): Drug Safety Communication – Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity AUDIENCE: Oncology, Hematology,┬áNeurology ISSUE: FDA notified healthcare professionals that two additional cases of progressive multifocal leukoencephalopathy (PML), … Continue reading

Share
Posted in FDA 2011, FDA Label Change, FDA Notice, FDA Warning, Hematology, Neurology, Oncology | Tagged , , , , , , , , , | Comments Off